These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 33244799)
1. Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX-2 inhibitors. Kaya Çavuşoğlu B; Sağlık BN; Acar Çevik U; Osmaniye D; Levent S; Özkay Y; Kaplancıklı ZA Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000273. PubMed ID: 33244799 [TBL] [Abstract][Full Text] [Related]
2. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity. Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 1,3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1/-2 inhibitors. Zarghi A; Zebardast T; Hakimion F; Shirazi FH; Rao PN; Knaus EE Bioorg Med Chem; 2006 Oct; 14(20):7044-50. PubMed ID: 16798002 [TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, Docking Studies, Enzyme Inhibitory and Antiplatelet Aggregation Activities of New 1,3-Diphenyl-3-(Phenylthio)Propan-1-One Derivatives as Selective COX-2 Inhibitors. Bayanati M; Daraei B; Zarghi A Anticancer Agents Med Chem; 2023; 23(2):192-200. PubMed ID: 35692149 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Evaluation of 1,3,5-Trisubstituted 2-Pyrazolines as Novel Cyclooxygenase-2 Inhibitors with Antiproliferative Activity. Vahedpour T; Kaur J; Hemmati S; Hamzeh-Mivehroud M; Alizadeh AA; Wuest F; Dastmalchi S Chem Biodivers; 2021 Mar; 18(3):e2000832. PubMed ID: 33620122 [TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, Ahmadi N; Khoramjouy M; Movahed MA; Amidi S; Faizi M; Zarghi A Anticancer Agents Med Chem; 2024; 24(7):504-513. PubMed ID: 38275051 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of new compounds bearing methyl sulfonyl pharmacophore as selective COX-2 inhibitor. Almarsoomi T; Osmaniye D; Sağlık BN; Levent S; Ghani U; Özkay Y; Kaplancıklı ZA J Mol Recognit; 2023 Jul; 36(7):e3025. PubMed ID: 37191245 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety. Sağlık BN; Osmaniye D; Levent S; Çevik UA; Çavuşoğlu BK; Özkay Y; Kaplancıklı ZA Eur J Med Chem; 2021 Jan; 209():112918. PubMed ID: 33071054 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of new 1,4-diarylazetidin-2-one derivatives (β-lactams) as selective cyclooxygenase-2 inhibitors. Arefi H; Naderi N; Shemirani ABI; Kiani Falavarjani M; Azami Movahed M; Zarghi A Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900293. PubMed ID: 31917485 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship of novel series of 1,5-disubstituted tetrazoles as cyclooxygenase-2 inhibitors: Design, synthesis, bioassay screening and molecular docking studies. Jawabrah Al-Hourani B; Al-Awaida W; Matalka KZ; El-Barghouthi MI; Alsoubani F; Wuest F Bioorg Med Chem Lett; 2016 Oct; 26(19):4757-4762. PubMed ID: 27567369 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of Hydroxybenzofuranyl-pyrazolyl and Hydroxyphenyl-pyrazolyl Chalcones and Their Corresponding Pyrazoline Derivatives as COX Inhibitors, Anti-inflammatory and Gastroprotective Agents. Ragab FAE; Mohammed EI; Abdel Jaleel GA; Selim AAMAE; Nissan YM Chem Pharm Bull (Tokyo); 2020; 68(8):742-752. PubMed ID: 32741915 [TBL] [Abstract][Full Text] [Related]
13. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation. Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents. Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors. Lamie PF; Philoppes JN; Rárová L Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of new indole-based chalcones as potential antiinflammatory agents. Özdemir A; Altintop MD; Turan-Zitouni G; Çiftçi GA; Ertorun İ; Alataş Ö; Kaplancikli ZA Eur J Med Chem; 2015 Jan; 89():304-9. PubMed ID: 25462246 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors. Ghodsi R; Zarghi A; Daraei B; Hedayati M Bioorg Med Chem; 2010 Feb; 18(3):1029-33. PubMed ID: 20061161 [TBL] [Abstract][Full Text] [Related]
18. Click chemistry synthesis, biological evaluation and docking study of some novel 2'-hydroxychalcone-triazole hybrids as potent anti-inflammatory agents. Boshra AN; Abdu-Allah HHM; Mohammed AF; Hayallah AM Bioorg Chem; 2020 Jan; 95():103505. PubMed ID: 31901755 [TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of methoxyphenyl- and coumarin-based chalcone derivatives as anti-inflammatory agents by inhibition of NO production and down-regulation of NF-κB in LPS-induced RAW264.7 macrophage cells. Emam SH; Sonousi A; Osman EO; Hwang D; Kim GD; Hassan RA Bioorg Chem; 2021 Feb; 107():104630. PubMed ID: 33476864 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibition. El-Husseiny WM; El-Sayed MA; El-Azab AS; AlSaif NA; Alanazi MM; Abdel-Aziz AA J Enzyme Inhib Med Chem; 2020 Dec; 35(1):744-758. PubMed ID: 32183576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]